When to increase and decrease burden of treatment for breast cancer patients

Share :
Published: 28 Jan 2019
Views: 1382
Rating:
Save
Prof Pierre Conte - Istituto Oncologico Veneto, Padova, Italy

Prof Pierre Conte speaks to ecancer at BGICC 2019 in Cairo about the question of when to increase the burden of treatment for patients at high risk of relapse, and when to decrease treatment for patients who have a good prognosis.

He speaks about subgroups of breast cancer patients that might benefit from alternative treatment approaches.

Prof Conte concludes that some countries with limited resources could benefit from understanding when it is safe to stop administering trastuzumab to subgroups of patients with a low chance of relapse.